Profile

    Corporate information

    Official name
    Aposense Limited

    Registration country
    Investment activity status
    Active investor

    Company type

    A clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology.

    Funding rounds

    (23 May 2010)

    Profile Country Notes
    Ziegler Meditech Equity Partners LP United States

    Current and past shareholders